iBeam Technology Discusses Global CRO Cooperation at BioJapan
Pursues collaboration with Shionogi and others on in vivo imaging-based nonclinical research
Confirms 13 follow-up meetings; discusses partnerships with Epsilon Molecular Engineering and others
iBeam Technology is targeting the global pharmaceutical and biotech markets with its contract research organization (CRO) business based on bioimaging.
iBeam Technology said on October 13 that it had participated in BioJapan 2026, held in Yokohama, Japan, from October 7 to 9, where it discussed business cooperation with global pharmaceutical and biotech companies and research institutions. It was the company’s first global event since reorganizing its CRO division in July.
At the event, iBeam Technology secured a total of 13 follow-up meetings, including one with Shionogi, and identified new business opportunities. It discussed potential collaboration on in vivo imaging-based CRO services for central nervous system (CNS) diseases with the department at Shionogi responsible for identifying new technologies and research seeds. The company is also in discussions with two companies, including Epsilon Molecular Engineering (EME), on partnerships and memorandum of understanding (MOU) agreements.
The company reorganized its CRO division to expand its customer base beyond academia into the pharmaceutical, biotech, and medical industries. Its strategy is to combine in vivo live-cell imaging technology with research services to meet global pharmaceutical companies’ demand for nonclinical studies. The company said that this technology, which directly observes cellular changes in vivo, can be used to assess the efficacy and mechanisms of action of drug candidates.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Kim Pilhan, CEO of iBeam Technology, said, "At our first external event since the reorganization, we saw strong interest from global pharmaceutical companies. We will now step up our efforts to expand global sales, leveraging our bioimaging CRO capabilities."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.